InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Holland David, Directeur Marketing. Director active across 1 company, notably Alimera Sciences INC. In total, 12 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €35k. Activity tracked since 30 April 2021. The latest transaction was filed on 26 March 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
187,756 sharesCommon StockSEC:0001104659-24-101113:0
68,000 shares0Common StockSEC:0000899243-23-009831:0
500 shares@ US$4.4374.9% of flowCommon StockSEC:0001762007-22-000002:0
500 shares@ US$3.7574.1% of flowCommon StockSEC:0001474506-22-000039:0
8,750 shares0Common StockSEC:0001474506-22-000012
8,750 shares0Common StockSEC:0001474506-22-000012:0
5,000 shares@ US$4.078340.8% of flowCommon StockSEC:0001474506-21-000156:0
Ideal exit: 31 Jul 2022 (T+270)
5,000 shares@ US$4.078385.1% of flowCommon StockSEC:0001474506-21-000156
Ideal exit: 31 Jul 2022 (T+270)
500 shares@ US$3.7573.7% of flowCommon StockSEC:0001474506-21-000155:0
500 shares@ US$3.7573.5% of flowCommon StockSEC:0001474506-21-000155
500 shares@ US$3.56153.4% of flowCommon StockSEC:0001474506-21-000085
500 shares@ US$3.56153.4% of flowCommon StockSEC:0001474506-21-000085:0
12 of 12 declarations
About Holland David
David Holland is Chief Marketing Officer and Senior Vice President at Alimera Sciences Inc, a biopharmaceutical company. He leads marketing and strategic initiatives aimed at enhancing brand presence and driving growth.
